Part: 12         Session: 145678910111213141516171819202122         Page 732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792 of 999

And it was to be coordinated and collated there.

Oh, yes. But you can't do very much unless you have big quantities of material. Because this is, cancer is a condition that happens all over the world, and viral disease happens all over the world. You've got to have an immense amount of material, so, whichever manufacturers make it first will, or are in the lead and make it best, will undoubtedly, ought to make a great fortune.

Well, I would think that the commercial stimulus of that would do it, would --

Well, we hope it will. But you know, they're always busy with other things, and they're always people without imagination, and there's always, there are always road blocks to any human effort. As you might have noticed.

Oh, yes. So, well, now, all of this going on in the world in the field of experimentation with interferon, has the NIH been budged to do anything?

Well, that I'll tell you about when we come into the appropriations.

I see. All right.

Because they have been extremely slow about it.

Even reluctant?

And reluctant, and they purchased some in 1976 and didn't give it out for over a year. After innumerable requests on the part of Gutterman and me that they should deliver some, they finally delivered it slightly over a year after they got it. They are not known to have any more at the present moment, although